These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2514 related items for PubMed ID: 11268324
1. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P. Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324 [Abstract] [Full Text] [Related]
2. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)]. Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA. Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349 [Abstract] [Full Text] [Related]
3. Allogeneic bone marrow transplantation versus chemotherapy in childhood very high risk acute lymphoblastic leukemia in first complete remission: a controversial issue. Uderzo C, Balduzzi A. Haematologica; 2002 Aug; 87(8 Suppl):47-50. PubMed ID: 12412390 [Abstract] [Full Text] [Related]
4. Indications and role of allogeneic bone marrow transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission. Uderzo C. Haematologica; 2000 Nov; 85(11 Suppl):9-11. PubMed ID: 11268333 [Abstract] [Full Text] [Related]
5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB. Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [Abstract] [Full Text] [Related]
6. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group. Borgmann A, Hartmann R, Schmid H, Klingebiel T, Ebell W, Göbel U, Peters C, Gadner H, Henze G. Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375 [Abstract] [Full Text] [Related]
7. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia]. Starý J, Kobylka P, Sedlácek P, Komrska V, Vávra V, Syrůcková Z, Smísek P, Hrubá A, Korínková P, Matĕjková E, Cukrová V, Dolezalová L, Loudová M, Sejkorová J, Kvĕch J. Cas Lek Cesk; 1998 Jun 15; 137(12):363-7. PubMed ID: 9721472 [Abstract] [Full Text] [Related]
8. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87. Einsiedel HG, von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G, Mann G, Hählen K, Göbel U, Klingebiel T, Ludwig WD, Henze G. J Clin Oncol; 2005 Nov 01; 23(31):7942-50. PubMed ID: 16258094 [Abstract] [Full Text] [Related]
9. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ. Biol Blood Marrow Transplant; 2008 Jun 01; 14(6):685-92. PubMed ID: 18489994 [Abstract] [Full Text] [Related]
10. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative? Borgmann A, Baumgarten E, Schmid H, Dopfer R, Ebell W, Göbel U, Niethammer D, Gadner H, Henze G. Bone Marrow Transplant; 1997 Dec 01; 20(11):939-44. PubMed ID: 9422472 [Abstract] [Full Text] [Related]
11. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group. Matsuzaki A, Nagatoshi Y, Inada H, Nakayama H, Yanai F, Ayukawa H, Kawakami K, Moritake H, Suminoe A, Okamura J. Pediatr Blood Cancer; 2005 Aug 01; 45(2):111-20. PubMed ID: 15782402 [Abstract] [Full Text] [Related]
12. Allogeneic BMT vs. chemotherapy in late bone marrow relapsed childhood non-T/non-B ALL: results of BFM ALL relapse studies. BFM Relapse Study Group. Schmid H, von Schenck U, Hartmann R, Borgmann A, Henze G. Bone Marrow Transplant; 1996 Nov 01; 18 Suppl 2():28-30. PubMed ID: 8932794 [Abstract] [Full Text] [Related]
13. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R. Exp Hematol; 1995 Dec 01; 23(14):1553-62. PubMed ID: 8542946 [Abstract] [Full Text] [Related]
14. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials. Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Plüss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H. Klin Padiatr; 1998 Dec 01; 210(4):192-9. PubMed ID: 9743952 [Abstract] [Full Text] [Related]
15. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia. Huck K, Laws HJ, Meisel R, Traeger A, Bernbeck B, Schonberger S, Stackelberg VA, Pape H, Dilloo D. Haematologica; 2006 May 01; 91(5 Suppl):ECR07. PubMed ID: 16709515 [Abstract] [Full Text] [Related]
16. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941. Gaynon PS, Harris RE, Altman AJ, Bostrom BC, Breneman JC, Hawks R, Steele D, Zipf T, Stram DO, Villaluna D, Trigg ME. J Clin Oncol; 2006 Jul 01; 24(19):3150-6. PubMed ID: 16717292 [Abstract] [Full Text] [Related]
17. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission]. Wang HH, Feng SZ, Wang M, Wei JL, Jiang EL, Zhang L, Huang Y, Zhou SY, Liu QG, Qiu LG, Han MZ, Yan WW. Zhonghua Xue Ye Xue Za Zhi; 2004 Jul 01; 25(7):389-92. PubMed ID: 15355688 [Abstract] [Full Text] [Related]
18. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group. Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, Lakomek M, Henze G, von Stackelberg A. J Clin Oncol; 2009 Jul 10; 27(20):3363-9. PubMed ID: 19433688 [Abstract] [Full Text] [Related]
19. Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia Pediatrica. Messina C, Valsecchi MG, Aricò M, Locatelli F, Rossetti F, Rondelli R, Cesaro S, Uderzo C, Conter V, Pession A, Sotti G, Loiacono G, Santoro N, Miniero R, Dini G, Favre C, Meloni G, Testi AM, Werner B, Silvestri D, Arrighini A, Varotto S, Pillon M, Basso G, Zanesco L. Bone Marrow Transplant; 1998 Jan 10; 21(1):9-14. PubMed ID: 9486488 [Abstract] [Full Text] [Related]
20. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children. Parsons SK, Castellino SM, Lehmann LE, Eickhoff CE, Tarbell NJ, Sallan SE, Weinstein HJ, Billett AL. Bone Marrow Transplant; 1996 May 10; 17(5):763-8. PubMed ID: 8733695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]